SCHEMBL5209685

SCHEMBL5209685

CC(=O)c1ccc(N2CCC(OC3CCN(C4CCC4)CC3)CC2)nc1

nearest known ligand 0.75

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 18/20 0.75
ADRA1A P35348 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5209555 0.88 HRH3 (0.60) HRH3ADRA1A
SCHEMBL5213411 0.88 HRH3 (0.60) HRH3ADRA1A
SCHEMBL5211791 0.88 HRH3 (0.59) HRH3ADRA1A
SCHEMBL5210990 0.86 HRH3 (0.60) HRH3ADRA1A
SCHEMBL4031778 0.86 HRH3 (0.66) HRH3ADRA1A
SCHEMBL14843953 0.86 HRH3 (1.00) HRH3
SCHEMBL5212512 0.86 HRH3 (0.61) HRH3ADRA1A
SCHEMBL5209593 0.83 ALDH1A1 (0.64) HRH3ADRA1A
SCHEMBL6117792 0.82 HRH3 (0.66) HRH3ADRA1A
SCHEMBL4936546 0.82 HRH3 (0.64) HRH3ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1646620-B1 SUBSTITUTED PIPERIDINES AS HISTAMINE H3 RECEPTOR LIGANDS GLAXO GROUP LTD (GB) 2007-08-15 EP claimed
EP-1646620-B1 SUBSTITUTED PIPERIDINES AS HISTAMINE H3 RECEPTOR LIGANDS GLAXO GROUP LTD (GB) 2007-08-15 EP disclosed
US-20060247227-A1 Substituted piperidines as histamine h3 receptor ligands BAILEY JAMES M 2006-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247227-A1 Substituted piperidines as histamine h3 receptor ligands HRH3, HRH4, HRH1 HRH3 1/4885ADRA1A 371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.